TickerFacts.

Anteris Technologies Global Corp. (AVR): Cost of Revenue

Annual figures by period end, from SEC filings.

$569.0K
Year ended 2025-12-31
$561.0K
Trailing 12 months to 2026-06-30
$1.44M2024-12-31: $1.44M2025-12-31: $569.0K$569.0K
2024-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$569.0K-60.4%2026-02-26, From 2025-01-01
2024-12-31$1.44Mn/a2026-02-26, From 2024-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Anteris Technologies Global Corp. (AVR)2025-12-31$569.0K-60.4%
NutriBand Inc. (NTRB)2026-01-31$1.47M+5.3%
CollPlant Biotechnologies Ltd (CLGN)2025-12-31$835.0K-48.6%
ENvue Medical, Inc. (FEED)2025-12-31$2.40M+128.6%
Safe Pro Group Inc. (SPAI)2025-12-31$404.5K-68.0%
Milestone Scientific Inc. (MLSS)2025-12-31$2.57M+16.9%
LogicMark, Inc. (LGMK)2025-12-31$3.79M+15.5%
Envoy Medical, Inc. (COCH)2025-12-31$874.0K+17.8%
Jin Medical International Ltd. (ZJYL)2025-09-30$14.64M+4.6%

Compare AVR, NTRB, CLGN, FEED side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗